XML 162 R143.htm IDEA: XBRL DOCUMENT v3.10.0.1
Employee Compensation and Benefit Plans - Schedule of Stock Option Activity (Details) - $ / shares
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Forfeited/Canceled (in shares) (4,719,750)    
Stock Options [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Outstanding (in shares) 6,708,655 [1],[2] 6,926,634 [1],[2] 7,151,225
Outstanding (in dollars per share) $ 9.97 [1],[2] $ 9.88 [1],[2] $ 10.10
Granted (in shares) [3],[4] 348,385    
Granted (in dollars per share) [3],[4] $ 3.66    
Exercised (in shares) [5],[6]     (69,805)
Exercised (in dollars per share) [5],[6]     $ 5.81
Forfeited/Canceled (in shares) [3] (4,964,441) (217,979) (154,786)
Forfeited/Canceled (in dollars per share) [3] $ 5.62 $ 7.16 $ 21.80
Outstanding (in shares) [1],[2] 2,092,599 6,708,655 6,926,634
Outstanding (in dollars per share) [1],[2] $ 19.22 $ 9.97 $ 9.88
Exercisable at end of year (in shares) [1],[2],[7] 1,520,039 6,234,830 6,344,958
Exercisable at end of year (in dollars per share) [1],[2],[7] $ 21.29 $ 8.87 $ 8.71
[1] At December 31, 2018, 160,000 options with a market condition for vesting based on an average common stock trading price of $38.94, had not met their performance criteria. Outstanding and exercisable stock options at December 31, 2018 have a net aggregate intrinsic value of $0. A total of 870,939 market-based options were outstanding at December 31, 2018, of which 710,939 were exercisable.
[2] At December 31, 2018, the weighted average remaining contractual term of options outstanding and options exercisable was 5.02 years and 3.87 years, respectively.
[3] Stock options granted in 2018 include 266,990 options awarded to Ocwen’s current Chief Executive Officer at an exercise price of $4.12 equal to the closing price of our common stock on the effective date of his employment, which was the closing date of the PHH acquisition.
[4] The weighted average grant date fair value of stock options granted in 2018 was $2.63.
[5] Includes 4,719,750 options which expired unexercised in 2018 because their exercise price was greater than the market price of Ocwen’s stock.
[6] The total intrinsic value of stock options exercised, which is defined as the amount by which the market value of the stock on the date of exercise exceeds the exercise price was $0.1 million in 2016.
[7] The total fair value of stock options that vested and became exercisable during 2018, 2017 and 2016, based on grant-date fair value, was $0.6 million, $0.7 million and $1.1 million, respectively.